Metamorphic thyroid autoimmunity

Thyroid

Volumn 18, Issue 10, 2008, Pages 1035-1037

  Ludgate, Marian ^a   Emerson, Charles H ^b  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MESSENGER RNA; RECOMBINASE; THYROID ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY;

ALTERNATIVE RNA SPLICING; APOPTOSIS; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; EDITORIAL; EUKARYOTIC CELL; FLOW CYTOMETRY; GENETIC SUSCEPTIBILITY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOLOGICAL TOLERANCE; METAMORPHOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; SOMATIC MUTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THYROID DISEASE; THYROID FUNCTION; THYROID GLAND; THYROTOXICOSIS;

AUTOIMMUNITY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; RECEPTORS, THYROTROPIN; THYROID GLAND;

EID: 53649109424     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.1551     Document Type: Editorial

References (36)

1. Champion B, Gopinath B, Ma G, El-Kaissi S 2008 Conversion to Graves' hyperthyroidism in a patient with hypothyroidism due to Hashimoto's thyroiditis documented by real-time thyroid ultrasonography. Thyroid 18:1135-1137.
2. Hidaka Y, Tatsumi KI 2008 Spontaneous transient Graves' thyrotoxicosis. Thyroid 18:1133-1134.
3. Amino N, Yabu Y, Mayai K, Fujie T, Azukizawa M, Onishi T, Kumahara Y 1978 Differentiation of thyrotoxicosis induced by thyroid destruction from Graves' disease. Lancet 12;2:344-346.
4. Hidaka IY, Tada H, Takano T, Kashiwai T, Tatsumi KI, Ichihara K, Amino N 2002 Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis. Clin Endocrinol (Oxf ) 57:51-58.
5. Kurita S, Sakurai M, Kita Y, Ota T, Ando H, Kaneko S, Takamura T 2005 Measurement of thyroid blood flow area is useful for diagnosing the cause of thyrotoxicosis. Thyroid 15:1249-1252.
6. Ohye H, Nishihara E, Sasaki I, Kubota S, Amino N, Kuma K, Miyauchi A 2006 Four cases of Graves' disease which developed after painful Hashimoto's thyroiditis. Intern Med 45:385-389.
7. McLachlan SM, Rapoport B 2004 Thyroid stimulating monoclonal antibodies: overcoming the road blocks and the way forward. Clin Endocrinol 61:10-18.
8. Schwarz-Lauer, Chazenbalk GD, Mclachlan SM, Ochi Y, Nagayama Y, Rapoport B 2002 Evidence for a simplified view of autoantibody interactions with the thyrotropin receptor. Thyroid 12:115-120.
9. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart G, Pardo L, Costagliola S 2003 Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. Embo J 22:2692-2703.
10. Costagliola S, Khoo D, Vassart G 1998 Production of bioactive amino-terminal domain of the thyrotropin receptor via insertion in the plasma membrane by a glycosylphosphatidylinositol anchor. FEBS Lett 436:427-433.
11. Metcalfe R, Jordan N, Watson P, Gullu S, Wiltshire M, Crisp M, Crisp M, Evans C, Weetman A, Ludgate M 2002 Demonstration of immunoglobulin G, A, and E autoantibodies to the human thyrotropin receptor using flow cytometry. J Clin Endocrinol Metab 87:1754-1761.
12. Vlaeminck-Guillem V, Ho SC, Rodien P, Vassart G, Costagliola S 2002 Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol Endocrinol 16:736-746.
13. Morgenthaler NG, Ho SC, Minich WB 2007 Stimulating and blocking thyroid-stimulating hormone (TSH) receptor autoantibodies from patients with Graves' disease and autoimmune hypothyroidism have very similar concentration, TSH receptor affinity, and binding sites. J Clin Endocrinol Metab 92:1058-1065.
14. Costagliola S, Bonomi M, Morgenthaler NG, Van Durme J, Panneels V, Refetoff S, Vassart G 2004 Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol 18:3020-3034.
15. Gillis D, Volpe R, Daneman D 1998 A young boy with a thyroid yo-yo. J Pediatr Endocrinol Metab 11:467-470.
16. Longo NS, Lipsky PE 2006 Why do B cells mutate their immunoglobulin receptors. Trends Immunol 27:374-380.
17. Yeh HC, Futterweit W, Gilbert P 1996 Micronodulation: ultrasonographic sign of Hashimoto thyroiditis. J Ultrasound Med 15:813-819.
18. Neale DM, Cootauco AC, Burrow G 2007 Thyroid disease in pregnancy. Clin Perinatol 34:543-557.
19. O'Connor MJ, Paget-Brown AO, Clarke WL 2007 Premature twins of a mother with Graves' disease with discordant thyroid function: a case report. J Perinatol 27:388-389.
20. Ando T, Latif R, Davies TF 2004 Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody. J Clin Invest 113:1589-1595.
21. Dechairo BM, Zabaneh D, Collins J, Brand O, Dawson GJ, Green AP, Mackay I, Franklyn JA, Connell JM, Wass JA, Wiersinga WM, Hegedus L, Brix T, Robinson BG, Hunt PJ, Weetman AP, Carey AH, Gough SC 2005 Association of the TSHR gene with Graves' disease: the first disease specific locus. Eur J Hum Genet 13:1223-1230.
22. Graves PN, Tomer Y, Davies TF 1992 Cloning and sequencing of a 1.3 KB variant of human thyrotropin receptor mRNA lacking the transmembrane domain. Biochem Biophys Res Commun 187:1135-1143.
23. Latif R, Ando T, Davies TF 2007 Lipid rafts are triage centers for multimeric and monomeric thyrotropin receptor regulation. Endocrinology 148:3164-3175.
24. Chen CR, Pichurin P, Nagayama Y, Latrofa F, Rapoport B, McLachlan SM 2003 The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. J Clin Invest 111:1897-1904.
25. Sequeira M, Jasani B, Fuhrer D, Wheeler M, Ludgate M 2002 Demonstration of reduced in vivo surface expression of activating mutant thyrotrophin receptors in thyroid sections. Eur J Endocrinol 146:163-171.
26. Chazenbalk GD, Kakinuma A, Jaume JC, McLachlan SM, Rapoport B 1996 Evidence for negative cooperativity among human thyrotropin receptors overexpressed in mammalian cells. Endocrinology 137:4586-4591.
27. high lymph node T cells: functional role for thyroid-stimulating hormone during immune activation. J Immunol 164:6158-6165.
28. Laurberg P, Wallin G, Tallstedt L, Abraham-Nordling M, Lundell G, Torring O 2008 TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 158:69-75.
29. Strasser A, Pellegrini M 2004 T-lymphocyte death during shutdown of an immune response. Trends Immunol 25:610-605.
30. Ariel A, Serhan CN 2007 Resolvins and protectins in the termination program of acute inflammation. Trends Immunol 28:176-183.
31. Iitaka M, Momotani N, Hisaoka T, Noh JY, Ishikawa N, Ishii J, Katayama S, Ito K 1998 TSH receptor antibody-associated thyroid dysfunction following subacute thyroiditis. Clin Endocrinol (Oxf ) 48:445-453.
32. Anderton SM 2006 Avoiding autoimmune disease - T Cells know their limits. Trends Immunol 27:208-214.
33. Wang YH, Diamond B 2008 B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice. J Clin Invest 118:2896-2907.
34. Armengol MP, Juan M, Lucas-Martin A, Fernandez-Figueras MT, Jaraquemada D, Gallart T, Pujol-Borrell R 2001 Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am J Pathol 159:861-873.
35. Zakarija M 1983 Immunochemical characterization of the thyroid-stimulating antibody (TSAb) of Graves' disease: evidence for restricted heterogeneity. J Clin Lab Immunol 10:77-85.
36. Smith BR, Sanders J, Furmaniak J 2007 TSH receptor antibodies. Thyroid 17:923-938.